Billable / Specific Code
ICD-10-CM C50.329 is the diagnosis code for Malignant neoplasm of lower-inner quadrant of unspecified male breast. This code falls under the section "Malignant neoplasms of breast" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where C50.329 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C50.329 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C50.329 is the ICD-10-CM diagnosis code for "Malignant neoplasm of lower-inner quadrant of unspecified male breast". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C50.329 is C50.32 ("Malignant neoplasm of lower-inner quadrant of breast, male"). C50.329 provides a more specific classification within this category.
C50.329 is located in Section C50 — "Malignant neoplasms of breast" within Chapter 2 of the ICD-10-CM Tabular List.
Use C50.329 when the patients documented diagnosis matches "Malignant neoplasm of lower-inner quadrant of unspecified male breast" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of lower-inner quadrant of unspecified male breast is C50.329.
Yes, C50.329 can be used as a primary diagnosis code since it is billable and specific.
C50.329 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C50.329 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.